Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial.
Xiangbing DengQingbin WuLiang BiYongyang YuShuo HuangDu HeBing WuHongfeng GouWenjian MengMeng QiuYazhou HeZiqiang WangPublished in: The British journal of surgery (2021)
NCT03666442 (http://www.clinicaltrials.gov).